NASD · Healthcare · Medical Devices · USA
SS Innovations International Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.
SS Innovations International Inc designs and manufactures the SSi Mantra, a surgical robotic system for procedures across multiple medical specialties. The company generates revenue from system sales via outright purchase, installment payments, and pay-per-procedure models, plus recurring income from instruments, accessories and services. Operating primarily in India with installations in several other countries, it sells systems directly and through distributors.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the SS Innovations International Inc stock.
Overvalued: intrinsic value $0.38 per share, market price $1.33, margin of safety -249.4% (as of 2026-11-17).
A 1.6x revenue multiple, discounted for its losses, values the shares at $0.38; the price of $1.33 is 249% above that value.
All 140 Medical Devices stocks
45 more in this industry show a wider margin of safety.
SSII is overvalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $0.38; the price of $1.33 is 249% above that value.
$0.38 per share (as of the 2026-11-17 close), against a market price of $1.33. That is a margin of safety of -249.4%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.